{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:25:27Z","timestamp":1790792727338,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T00:00:00Z","timestamp":1545350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007903","name":"Bloodwise","doi-asserted-by":"publisher","award":["10027"],"award-info":[{"award-number":["10027"]}],"id":[{"id":"10.13039\/501100007903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10495-018-1506-3","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T09:24:05Z","timestamp":1545384245000},"page":"145-156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Mechanisms of cell death induced by arginase and asparaginase in precursor B-cell lymphoblasts"],"prefix":"10.1007","volume":"24","author":[{"given":"Lucy E.","family":"M\u00e9tayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Carlebur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. A. Amos","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy C.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,21]]},"reference":[{"issue":"22","key":"1506_CR1","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1001\/jama.2011.747","volume":"305","author":"RC Reulen","year":"2011","unstructured":"Reulen RC, Frobisher C, Winter DL et al (2011) Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA 305(22):2311\u20132319","journal-title":"JAMA"},{"issue":"10","key":"1506_CR2","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1200\/JCO.2004.11.120","volume":"22","author":"F Izzo","year":"2004","unstructured":"Izzo F, Marra P, Beneduce G et al (2004) Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I\/II studies. J Clin Oncol 22(10):1815\u20131822","journal-title":"J Clin Oncol"},{"issue":"30","key":"1506_CR3","doi-asserted-by":"publisher","first-page":"7660","DOI":"10.1200\/JCO.2005.02.0933","volume":"23","author":"PA Ascierto","year":"2005","unstructured":"Ascierto PA, Scala S, Castello G et al (2005) Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies. J Clin Oncol 23(30):7660\u20137668","journal-title":"J Clin Oncol"},{"issue":"6","key":"1506_CR4","first-page":"1373","volume":"18","author":"JH Kim","year":"2007","unstructured":"Kim JH, Yu YS, Kim DH, Min BH, Kim KW (2007) Anti-tumor activity of arginine deiminase via arginine deprivation in retinoblastoma. Oncol Rep 18(6):1373\u20131377","journal-title":"Oncol Rep"},{"issue":"2","key":"1506_CR5","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1158\/0008-5472.CAN-08-3157","volume":"69","author":"RH Kim","year":"2009","unstructured":"Kim RH, Coates JM, Bowles TL et al (2009) Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. Cancer Res 69(2):700\u2013708","journal-title":"Cancer Res"},{"issue":"5","key":"1506_CR6","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/sj.leu.2401763","volume":"14","author":"H Gong","year":"2000","unstructured":"Gong H, Zolzer F, von Recklinghausen G, Havers W, Schweigerer L (2000) Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cycle arrest and apoptosis. Leukemia 14(5):826\u2013829","journal-title":"Leukemia"},{"issue":"2","key":"1506_CR7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/0003-9861(56)90144-8","volume":"62","author":"OA Roholt Jr","year":"1956","unstructured":"Roholt OA Jr, Greenberg DM (1956) Liver arginase. IV. Effect of pH on kinetics of manganese-activated enzyme. Arch Biochem Biophys 62(2):454\u2013470","journal-title":"Arch Biochem Biophys"},{"issue":"7","key":"1506_CR8","first-page":"BR248","volume":"8","author":"BJ Dillon","year":"2002","unstructured":"Dillon BJ, Holtsberg FW, Ensor CM, Bomalaski JS, Clark MA (2002) Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production. Med Sci Monit 8(7):BR248\u2013B53","journal-title":"Med Sci Monit"},{"issue":"25","key":"1506_CR9","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.1182\/blood-2009-12-258822","volume":"115","author":"CP Hernandez","year":"2010","unstructured":"Hernandez CP, Morrow K, Lopez-Barcons LA et al (2010) Pegylated arginase I: a potential therapeutic approach in T-ALL. Blood 115(25):5214\u20135221","journal-title":"Blood"},{"issue":"3","key":"1506_CR10","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/leu.2012.247","volume":"27","author":"K Morrow","year":"2013","unstructured":"Morrow K, Hernandez CP, Raber P et al (2013) Anti-leukemic mechanisms of pegylated arginase I in acute lymphoblastic T-cell leukemia. Leukemia 27(3):569\u2013577","journal-title":"Leukemia"},{"issue":"15","key":"1506_CR11","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2014-09-600643","volume":"125","author":"F Mussai","year":"2015","unstructured":"Mussai F, Egan S, Higginbotham-Jones J et al (2015) Arginine dependence of acute myeloid leukaemia blast proliferation: a novel therapeutic target. Blood 125(15):2386\u20132396","journal-title":"Blood"},{"issue":"8","key":"1506_CR12","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.1128\/MCB.15.8.4497","volume":"15","author":"SA Wek","year":"1995","unstructured":"Wek SA, Zhu S, Wek RC (1995) The histidyl-tRNA synthetase-related sequence in the eIF-2 alpha protein kinase GCN2 interacts with tRNA and is required for activation in response to starvation for different amino acids. Mol Cell Biol 15(8):4497\u20134506","journal-title":"Mol Cell Biol"},{"issue":"5","key":"1506_CR13","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S1097-2765(00)00108-8","volume":"6","author":"HP Harding","year":"2000","unstructured":"Harding HP, Novoa I, Zhang Y et al (2000) Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell 6(5):1099\u20131108","journal-title":"Mol Cell"},{"issue":"31","key":"1506_CR14","doi-asserted-by":"publisher","first-page":"11269","DOI":"10.1073\/pnas.0400541101","volume":"101","author":"KM Vattem","year":"2004","unstructured":"Vattem KM, Wek RC (2004) Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc Natl Acad Sci USA 101(31):11269\u201311274","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"1506_CR15","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/sj.embor.7400779","volume":"7","author":"E Szegezdi","year":"2006","unstructured":"Szegezdi E, Logue SE, Gorman AM, Samali A (2006) Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 7(9):880\u2013885","journal-title":"EMBO Rep"},{"issue":"33","key":"1506_CR16","doi-asserted-by":"publisher","first-page":"29408","DOI":"10.1074\/jbc.M110.197665","volume":"286","author":"X Tian","year":"2011","unstructured":"Tian X, Ye J, Alonso-Basanta M, Hahn SM, Koumenis C, Dorsey JF (2011) Modulation of CCAAT\/enhancer binding protein homologous protein (CHOP)-dependent DR5 expression by nelfinavir sensitizes glioblastoma multiforme cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J Biol Chem 286(33):29408\u201329416","journal-title":"J Biol Chem"},{"issue":"23","key":"1506_CR17","doi-asserted-by":"publisher","first-page":"14484","DOI":"10.1074\/jbc.273.23.14484","volume":"273","author":"K Hara","year":"1998","unstructured":"Hara K, Yonezawa K, Weng QP, Kozlowski MT, Belham C, Avruch J (1998) Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J Biol Chem 273(23):14484\u201314494","journal-title":"J Biol Chem"},{"issue":"4","key":"1506_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2174\/156652410791316995","volume":"10","author":"N Savaraj","year":"2010","unstructured":"Savaraj N, You M, Wu C, Wangpaichitr M, Kuo MT, Feun LG (2010) Arginine deprivation, autophagy, apoptosis (AAA) for the treatment of melanoma. Curr Mol Med 10(4):405\u2013412","journal-title":"Curr Mol Med"},{"issue":"1\u20132","key":"1506_CR19","first-page":"181","volume":"374","author":"M You","year":"2012","unstructured":"You M, Savaraj N, Kuo MT et al (2012) TRAIL induces autophagic protein cleavage through caspase activation in melanoma cell lines under arginine deprivation. Mol Cell Biochem 374(1\u20132):181\u2013190","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"1506_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1593\/tlo.10265","volume":"4","author":"ES Glazer","year":"2011","unstructured":"Glazer ES, Stone EM, Zhu C, Massey KL, Hamir AN, Curley SA (2011) Bioengineered human arginase I with enhanced activity and stability controls hepatocellular and pancreatic carcinoma xenografts. Transl Oncol 4(3):138\u2013146","journal-title":"Transl Oncol"},{"key":"1506_CR21","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1038\/cddis.2013.359","volume":"4","author":"X Zeng","year":"2013","unstructured":"Zeng X, Li Y, Fan J et al (2013) Recombinant human arginase induced caspase-dependent apoptosis and autophagy in non-Hodgkin\u2019s lymphoma cells. Cell Death Dis 4:e840","journal-title":"Cell Death Dis"},{"issue":"11","key":"1506_CR22","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.leukres.2013.08.007","volume":"37","author":"R Tanios","year":"2013","unstructured":"Tanios R, Bekdash A, Kassab E et al (2013) Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells. Leuk Res 37(11):1565\u20131571","journal-title":"Leuk Res"},{"key":"1506_CR23","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1038\/cddis.2012.83","volume":"3","author":"B Delage","year":"2012","unstructured":"Delage B, Luong P, Maharaj L et al (2012) Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis. Cell Death Dis 3:e342","journal-title":"Cell Death Dis"},{"issue":"8","key":"1506_CR24","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.freeradbiomed.2009.02.001","volume":"46","author":"RD Brown","year":"2009","unstructured":"Brown RD, Burke GA, Brown GC (2009) Dependence of leukemic cell proliferation and survival on H2O2 and L-arginine. Free Radic Biol Med 46(8):1211\u20131220","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"1506_CR25","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1054\/bjoc.2000.1353","volume":"83","author":"L Scott","year":"2000","unstructured":"Scott L, Lamb J, Smith S, Wheatley DN (2000) Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells. Br J Cancer 83(6):800\u2013810","journal-title":"Br J Cancer"},{"issue":"3","key":"1506_CR26","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ijc.20435","volume":"112","author":"EJ Noh","year":"2004","unstructured":"Noh EJ, Kang SW, Shin YJ et al (2004) Arginine deiminase enhances dexamethasone-induced cytotoxicity in human T-lymphoblastic leukemia CCRF-CEM cells. Int J Cancer 112(3):502\u2013508","journal-title":"Int J Cancer"},{"issue":"26","key":"1506_CR27","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1182\/blood-2014-10-608133","volume":"125","author":"F Miraki-Moud","year":"2015","unstructured":"Miraki-Moud F, Ghazaly E, Ariza-McNaughton L et al (2015) Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo. Blood 125(26):4060\u20134068","journal-title":"Blood"},{"issue":"5","key":"1506_CR28","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.1007\/s13277-015-4253-x","volume":"37","author":"Y Li","year":"2016","unstructured":"Li Y, Zeng X, Wang S et al (2016) Blocking autophagy enhanced leukemia cell death induced by recombinant human arginase. Tumour Biol 37(5):6627\u20136635","journal-title":"Tumour Biol"},{"issue":"4","key":"1506_CR29","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s10495-008-0303-9","volume":"14","author":"O Kepp","year":"2009","unstructured":"Kepp O, Tesniere A, Schlemmer F et al (2009) Immunogenic cell death modalities and their impact on cancer treatment. Apoptosis 14(4):364\u2013375","journal-title":"Apoptosis"},{"issue":"3","key":"1506_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00280-016-3236-y","volume":"79","author":"C Lanvers-Kaminsky","year":"2017","unstructured":"Lanvers-Kaminsky C (2017) Asparaginase pharmacology: challenges still to be faced. Cancer Chemother Pharmacol 79(3):439\u2013450","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"1506_CR31","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1182\/blood.V60.6.1305.1305","volume":"60","author":"HW Findley Jr","year":"1982","unstructured":"Findley HW Jr, Cooper MD, Kim TH, Alvarado C, Ragab AH (1982) Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes. Blood 60(6):1305\u20131309","journal-title":"Blood"},{"issue":"1","key":"1506_CR32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1182\/blood.V81.1.151.151","volume":"81","author":"T Miyashita","year":"1993","unstructured":"Miyashita T, Reed JC (1993) Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81(1):151\u2013157","journal-title":"Blood"},{"issue":"1","key":"1506_CR33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1158\/0008-5472.CAN-06-1945","volume":"67","author":"PN Cheng","year":"2007","unstructured":"Cheng PN, Lam TL, Lam WM et al (2007) Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion. Cancer Res 67(1):309\u2013317","journal-title":"Cancer Res"},{"issue":"11","key":"1506_CR34","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.freeradbiomed.2003.08.003","volume":"35","author":"V Borutaite","year":"2003","unstructured":"Borutaite V, Brown GC (2003) Nitric oxide induces apoptosis via hydrogen peroxide, but necrosis via energy and thiol depletion. Free Radic Biol Med 35(11):1457\u20131468","journal-title":"Free Radic Biol Med"},{"key":"1506_CR35","volume-title":"Means to an end: apoptosis and other cell death mechanisms","author":"DR Green","year":"2010","unstructured":"Green DR (2010) Means to an end: apoptosis and other cell death mechanisms. Cold Spring Harbour Laboratory Press, New York"},{"issue":"1","key":"1506_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1242\/jcs.174631","volume":"129","author":"TC Hornik","year":"2016","unstructured":"Hornik TC, Vilalta A, Brown GC (2016) Activated microglia cause reversible apoptosis of pheochromocytoma cells, inducing their cell death by phagocytosis. J Cell Sci 129(1):65\u201379","journal-title":"J Cell Sci"},{"issue":"3","key":"1506_CR37","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1582-4934.2005.tb00493.x","volume":"9","author":"N Seiler","year":"2005","unstructured":"Seiler N, Raul F (2005) Polyamines and apoptosis. J Cell Mol Med 9(3):623\u2013642","journal-title":"J Cell Mol Med"},{"issue":"14","key":"1506_CR38","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/sj.onc.1201704","volume":"16","author":"M Brimmell","year":"1998","unstructured":"Brimmell M, Mendiola R, Mangion J, Packham G (1998) BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability. Oncogene 16(14):1803\u20131812","journal-title":"Oncogene"},{"issue":"3","key":"1506_CR39","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","volume":"136","author":"P Nicklin","year":"2009","unstructured":"Nicklin P, Bergman P, Zhang B et al (2009) Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136(3):521\u2013534","journal-title":"Cell"},{"issue":"5","key":"1506_CR40","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1182\/blood-2010-07-298422","volume":"117","author":"MN Offman","year":"2011","unstructured":"Offman MN, Krol M, Patel N et al (2011) Rational engineering of L-asparaginase reveals importance of dual activity for cancer cell toxicity. Blood 117(5):1614\u20131621","journal-title":"Blood"},{"issue":"5","key":"1506_CR41","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00280-007-0421-z","volume":"60","author":"S Tardito","year":"2007","unstructured":"Tardito S, Uggeri J, Bozzetti C et al (2007) The inhibition of glutamine synthetase sensitizes human sarcoma cells to L-asparaginase. Cancer Chemother Pharmacol 60(5):751\u2013758","journal-title":"Cancer Chemother Pharmacol"},{"issue":"20","key":"1506_CR42","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1182\/blood-2013-03-493163","volume":"122","author":"L Willems","year":"2013","unstructured":"Willems L, Jacque N, Jacquel A et al (2013) Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia. Blood 122(20):3521\u20133532","journal-title":"Blood"},{"issue":"24","key":"1506_CR43","doi-asserted-by":"publisher","first-page":"7605","DOI":"10.1158\/1078-0432.CCR-11-0513","volume":"17","author":"H Ehrhardt","year":"2011","unstructured":"Ehrhardt H, Wachter F, Maurer M, Stahnke K, Jeremias I (2011) Important role of caspase-8 for chemosensitivity of ALL cells. Clin Cancer Res 17(24):7605\u20137613","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1506_CR44","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF00685615","volume":"32","author":"MD Story","year":"1993","unstructured":"Story MD, Voehringer DW, Stephens LC, Meyn RE (1993) L-asparaginase kills lymphoma cells by apoptosis. Cancer Chemother Pharmacol 32(2):129\u2013133","journal-title":"Cancer Chemother Pharmacol"},{"issue":"11","key":"1506_CR45","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1038\/sj.leu.2400834","volume":"11","author":"T Ueno","year":"1997","unstructured":"Ueno T, Ohtawa K, Mitsui K, Kodera Y, Hiroto M, Matsushima A, Inada Y, Nishimura H (1997) Cell cycle arrest and apoptosis of leukemia cells induced by L-asparaginase. Leukemia 11(11):1858\u20131861","journal-title":"Leukemia"},{"issue":"13","key":"1506_CR46","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1182\/blood-2002-11-3612","volume":"102","author":"A Holleman","year":"2003","unstructured":"Holleman A, den Boer ML, Kazemier KM, Janka-Schaub GE, Pieters R (2003) Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia. Blood 102(13):4541\u20134546","journal-title":"Blood"},{"issue":"6","key":"1506_CR47","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1182\/blood-2007-03-080325","volume":"110","author":"MH Kang","year":"2007","unstructured":"Kang MH, Kang YH, Szymanska B et al (2007) Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo. Blood 110(6):2057\u20132066","journal-title":"Blood"},{"issue":"2","key":"1506_CR48","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/sj.cdd.4402044","volume":"14","author":"D Chauvier","year":"2007","unstructured":"Chauvier D, Ankri S, Charriaut-Marlangue C, Casimir R, Jacotot E (2007) Broad-spectrum caspase inhibitors: from myth to reality? Cell Death Differ 14(2):387\u2013391","journal-title":"Cell Death Differ"},{"key":"1506_CR49","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2741\/4222","volume":"19","author":"Y He","year":"2014","unstructured":"He Y, Li B, Zhang H et al (2014) L-asparaginase induces in AML U937 cells apoptosis via an AIF-mediated mechanism. Front Biosci (Landmark Ed) 19:515\u2013527","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"5","key":"1506_CR50","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s00726-013-1586-x","volume":"45","author":"B Vynnytska-Myronovska","year":"2013","unstructured":"Vynnytska-Myronovska B, Kurlishchuk Y, Bobak Y, Dittfeld C, Kunz-Schughart LA, Stasyk O (2013) Three-dimensional environment renders cancer cells profoundly less susceptible to a single amino acid starvation. Amino Acids 45(5):1221\u20131230","journal-title":"Amino Acids"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10495-018-1506-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-018-1506-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-018-1506-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T19:03:33Z","timestamp":1576868613000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10495-018-1506-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,21]]},"references-count":50,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1506"],"URL":"https:\/\/doi.org\/10.1007\/s10495-018-1506-3","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,21]]},"assertion":[{"value":"21 December 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval for the use of human cells was granted by the University of Cambridge Human Biology Research Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}